DR. CHAINARONG LIMVARAPUSS MD NPI 1053341784

NPI Details

DR. Chainarong Limvarapuss, MD is a hematology and oncology internal medicine in Vallejo, CA with 37 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Chainarong Limvarapuss, MD NPI is 1053341784. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

100 HOSPITAL DR
SUITE # 110
VALLEJO, CA
ZIP 94589-578
Phone: (707) 551-3300
Fax: (707) 551-3301

The NPI 1053341784 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Injection, heparin sodium, (heparin lock flush), per 10 units (HCPCS:J1642)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Infusion, albumin (human), 25%, 20 ml (HCPCS:P9046)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Liver function blood test panel (HCPCS:80076)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Magnesium level (HCPCS:83735)
• Unclassified drugs (HCPCS:J3490)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Ferritin (blood protein) level (HCPCS:82728)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Folic acid level, serum (HCPCS:82746)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Injection of drug or substance into vein (HCPCS:96374)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• 5% dextrose/water (500 ml = 1 unit) (HCPCS:J7060)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Blood test, clotting time (HCPCS:85610)
• Injection, alteplase recombinant, 1 mg (HCPCS:J2997)
• Alpha-fetoprotein (afp) level, serum (HCPCS:82105)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• Drawing of blood for a medical problem (HCPCS:99195)
• Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow (HCPCS:G0181)
• Injection, hydromorphone, up to 4 mg (HCPCS:J1170)
• Hospital discharge day management, more than 30 minutes (HCPCS:99239)
• Critical care, first 30-74 minutes (HCPCS:99291)
• Declotting of central venous tube (HCPCS:36593)
• Critical care, each additional 30 minutes (HCPCS:99292)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and (HCPCS:G0180)
• Aspiration of bone marrow sample for diagnosis (HCPCS:38220)
• Biopsy of bone marrow (HCPCS:38221)

The enumeration date for this NPI number is 7/5/2006 and was last updated on 3/4/2011.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.